87 studies found for:    cancer | butyrate
Show Display Options
RSS Create an RSS feed from your search for:
cancer | butyrate
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Conditions: Leukemia;   Lymphoma;   Precancerous Condition;   Small Intestine Cancer
Interventions: Drug: arginine butyrate;   Drug: ganciclovir
2 Completed Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
Conditions: Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: chemotherapy;   Drug: tributyrin
3 Unknown  Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: lenalidomide;   Drug: therapeutic hydrocortisone
4 Recruiting Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer
Condition: Prostate Cancer
Interventions: Dietary Supplement: calcitriol;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
5 Terminated A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: aminoglutethimide;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
6 Completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: suramin;   Drug: therapeutic hydrocortisone;   Procedure: orchiectomy
7 Recruiting Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
Conditions: Colorectal Cancer;   Head and Neck Cancer
Interventions: Drug: Doxycycline;   Drug: Hydrocortisone 1% cream;   Other: Sunscreen;   Other: Moisturizer;   Drug: Clindamycin;   Drug: Medrol-dose pack (Steroid)
8 Suspended Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Conditions: Adenosquamous Lung Carcinoma;   Bronchioloalveolar Carcinoma;   Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Squamous Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Carboplatin;   Other: Hydrocortisone/Placebo;   Drug: Paclitaxel;   Drug: Veliparib
9 Completed Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Other: Withdrawal of antiandrogen therapy
10 Completed Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: sargramostim;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
11 Active, not recruiting Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: hydrocortisone;   Drug: dutasteride;   Drug: lapatinib
12 Withdrawn Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Condition: Prostate Cancer
Interventions: Drug: dexamethasone;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Procedure: pharmacological study
13 Completed Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
14 Terminated Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
Conditions: Lymphoid Malignancies;   Lymphoproliferative Disorders
Interventions: Drug: HQK-1004;   Drug: Valganciclovir (may substitute with ganciclovir)
15 Terminated Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
Conditions: EBV Lymphomas;   Lympho-proliferative Diseases
Interventions: Drug: Arginine Butyrate;   Drug: Ganciclovir;   Drug: Valganciclovir
16 Active, not recruiting Ketoconazole and Dexamethasone in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Ketoconazole, hydrocortisone;   Drug: Ketoconazole, dexamethasone
17 Completed Effect of Annona Muricata Leaves on Colorectal Cancer Patients and Colorectal Cancer Cells
Condition: Colorectal Cancer
Interventions: Dietary Supplement: Annona muricata extract;   Dietary Supplement: Placebo
18 Completed
Has Results
Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Ketoconazole, Hydrocortisone and Dutasteride
19 Completed Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Doxorubicin hydrochloride;   Drug: Estramustine Phosphate Sodium;   Drug: Flutamide;   Drug: Ketoconazole;   Drug: Nilutamide;   Drug: Therapeutic Hydrocortisone;   Drug: Vinblastine;   Procedure: Conventional Surgery
20 Recruiting 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: 177Lu-J591;   Drug: Ketoconazole;   Drug: Hydrocortisone;   Drug: 111In-J591

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years